DMNJ (KRIBB)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDMNJ (KRIBB)
Drug Alias Name(-)-1-Deoxymannojirimycinalpha glucosidase inhibitor (KRIBB)deoxymannojirimycin
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Neoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorean Research Institute of Bioscience and Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorean Research Institute of Bioscience and Biotechnology
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Neoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A